Corcept Therapeutics | CORT - 税前利润



金融业
股票价格
USD
资产
USD 836.65M
现金及等价物
USD 120.5M
销售成本
USD 2.55M
流动资产
USD 485.46M
流动负债
USD 166.09M
债务
USD 6.36M
EBIT
USD 4.49M
EBITDA
USD 4.2M
员工
500
EPS每股收益
USD 0.2
股本和储备
USD 647.81M
销售毛利
USD 199.58M
债务利息支出
USD 823.61M
利息收入
USD 5.02M
市值
USD 4.47B
净收入
USD 24.29M
营业费用
USD 197.64M
营业利润
USD 4.49M
普通股股本
USD 105.97M
PE价格收益
41.9
税前利润
USD 15.24M
销售收入
USD 202.12M
销售和管理费用
USD 114.75M
股票
USD 12.87M
贸易债权人
USD 40.44M
应收帐款人
USD 59.79M


税前利润 更改 日
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Ardelyx USD -400K 467K 2025-12
Assertio Holdings USD -2.88M 648K 2024-09
Aurora Cannabis CAD -1.58M 48.55M 2025-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Canopy Growth CAD -62.26M 60.84M 2025-12
Corcept Therapeutics USD 15.24M 16.45M 2025-09
Eli Lilly USD 7.23B 456M 2025-09
Esperion Therapeutics USD 63.67M 95M 2025-12
J&J USD 4.97B 2.53B 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Merck USD 6.74B 22M 2025-09
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Novartis USD 4.64B 445M 2025-12
Novartis USD 5.17B 637M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pacira USD 9.52M 11.45M 2025-09
Pfizer USD 3.33B 290M 2025-09
Supernus Pharmaceuticals USD -1.91M 56.04M 2025-12
TG Therapeutics USD 45.09M 19.18M 2025-12